Abstract:Background Diffusion-weighted (DW) imaging has shown potential to differentiate between malignant and benign breast lesions. However, different b values have been used with varied sensitivity and specificity. This study aims to prospectively evaluate the influence of b value on the detection and assessment of breast lesions. Methods Institutional review board approval and informed patient consent were obtained. Between February 2010 and September 2010, sixty women suspected of having breast cancer by clinical examination and mammography underwent bilateral breast MRI and DW imaging (with maximum b values of 600, 800, and 1000 s/mm 2 ). Conspicuity grades of lesions at different b values on DW images were performed. Signal intensity and apparent diffusion coefficient (ADC) values were recorded and compared among different b values by the signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR) and receiver operating characteristic (ROC) curve. Results Fifty-seven lesions from 52 recruited patients including 39/57 (68%) malignant and 18/57 (32%) benign were confirmed with pathology. DCE MRI accurately detected 53 lesions with the sensitivity of 93.0% and specificity of 66.7%, and DW imaging accurately detected 51 lesions with the sensitivity of 89.5% and specificity of 100%. There were no significant differences in conspicuity grades compared among the three b values ( P = 0.072), although the SNR and CNR of breast lesions decreased significantly with higher b values. Mean ADCs of malignant lesions (b = 600 s/mm 2 , 1.07 ± 0.26 × 10 -3 mm 2 /s; b = 800 s/mm 2 , 0.96 ± 0.22 × 10 -3 mm 2 /s; b = 1000 s/mm 2 , 0.92 ± 0.26 × 10 -3 mm 2 /s) were significantly lower than those of benign lesions (b = 600 s/mm 2 , 1.55 ± 0.40 × 10 -3 mm 2 /s; b = 800 s/mm 2 , 1.43 ± 0.38 × 10 -3 mm 2 /s; b = 1000 s/mm 2 , 1.49 ± 0.38 × 10 -3 mm 2 /s) with all P values <0.001, but there were no significant differences among the three b values ( P = 0.303 and 0.840 for malignant and benign lesions, respectively). According to the area under the ROC curves, which were derived from ADC and differentiate malignant from benign lesions, no significant differences were found among the three b values ( P = 0.743). Conclusions DW imaging is a potential adjunct to conventional MRI in the differentiation between malignant and benign breast lesions. Varying the maximum b value from 600 to 1000 s/mm 2 does not influence the conspicuity of breast lesions on DW imaging at 1.5 T.

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) in detection and characterization of neoplastic breast lesions

Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI

Accuracy and diagnostic value of diffusion-weighted whole body imaging with background body signal suppression (DWIBS) in metastatic breast cancer

MR Diffusion Weighted Imaging with Background Signal Suppression in Breast Cancer

The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?

Differentiation of Clinically Benign and Malignant Breast Lesions Using Diffusion-Weighted Imaging

The Role of Diffusion-Weighted Imaging and the Apparent Diffusion Coefficient (ADC) Values for Breast Tumors

Predictive Ability of DWI/ADC and DCE-MRI Kinetic Parameters in Differentiating Benign from Malignant Breast Lesions and in Building a Prediction Model.

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology

Comparative utility of MRI perfusion with MSIDR and DWIBS for the characterization of breast tumors.

2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience

Diffusion-weighted Imaging with Fat Suppression Using Short-Tau Inversion Recovery: Clinical Utility for Diagnosis of Breast Lesions.

Diffusion-Weighted Imaging for Skin Pathologies of the Breast—A Feasibility Study

Whole-body MRI with Diffusion-weighted Imaging for the Detection of Metastases after Surgical Resection for Breast Cancer

Whole-tumor apparent diffusion coefficient (ADC) analyses of breast lesions based on simultaneous multi-slice readout-segmented echo-planar diffusion-weighted imaging

Diffusion-Weighted Magnetic Resonance Imaging Combined with T2-Weighted Images in the Detection of Small Breast Cancer: A Single-Center Multi-Observer Study

Value of Diffusion Weighted Imaging on the Diagnosis and Differential Diagnosis of Breast Diseases

Detection of bone metastases through diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) compared with PET/CT 18F-NaF.

Conspicuity of Breast Lesions at Different B Values on Diffusion-Weighted Imaging

Diffusion-weighted MRI of the Breast: Lesion Characterization and Parameter Selection

Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions]